Loading...

Lululemon - A Fundamental and Historical Valuation

Published
19 Mar 26
Views
94
n/a
n/a
andre_santos's Fair Value
n/a
Loading
1Y
-58.5%
7D
-2.0%

Author's Valuation

US$266.1452.5% undervalued intrinsic discount

andre_santos's Fair Value

Business Overview

🎯Key Metrics

Total: 4/17

  • +1 ✅ Projected Operating Margin: 18.84%
  • +0 ⚠️ Projected 5-Year Revenue CAGR: 4.73%
  • +2 ✅✅ Last 5-Year ROIC: 45.98%
  • +1 ✅ Estimated Cost of Capital: 7.18% (lower than ROIC)
  • +1 ✅ Last 5-Year Shares Outstanding CAGR: -2.51%
  • -1 ❌ Projected 5-Year EPS CAGR: 6.92% (lower than 10%)
  • +0 ⚠️ Projected 5-Year Dividend CAGR: N/A
  • +2 ✅✅ Estimated Debt Rating: Aaa
  • -1 ❌ Morningstar Moat: Narrow
  • -1 ❌ Morningstar Uncertainty: High

📈Business Valuation

To calculate the intrinsic value of the company I'll use multiple methods:

  • Discounted Cash Flows (DCF) - Intrinsic value is estimated by projecting its free cash flows over the next 10 years and discounting them to present value using the estimated cost of capital;
  • EPS Growth - the fair value is estimated by projected the Earnings Per Share CAGR for the next 5 Years and then, given its current and historic values of PE, come up with a PE for the 5th Year. This will give us its price 5 Years from now using the formula: Price = EPS x PE that we then discount using the estimated cost of capital;
  • Historical EV/EBITDA - we assume mean reversion to the historical EV/EBITDA values;
  • Historical P/E - we assume mean reversion to the historical P/E values;
  • Historical P/S - we assume mean reversion to the historical P/S values.

I'll put more weight on the DCF and EPS methods and only then the historical ones. Given the ever-changing landscape of the world and the whole business the company operates, it seems unreasonable to assume a higher probability of mean reversion to the historical averages of the company.

Cost of Capital

I've used the latest annual financial statement of the company, the 10-Year Canada bonds as the risk free rate and revenue geographic exposure to come up with its cost of capital, cost of debt and cost of equity. Also, given the fact that Moody's does not provide a rating for the company I estimated it, internally, using its interest coverage ratio and then comparing it to similar rated companies.

Cost of Capital: 7.18%.

This value will be used later as a discount rate in the valuation methods.

Please feel free to come up with your own values by using the tool I've used: Cost of Capital - The Fair Value Journal. It is and will ever be completely free :)

Discounted Cash Flows (Weight: 50%)

I've used the latest annual financial statement of the company, the analyst estimates for both revenue and margins and the cost of capital calculated previously.

Some notes on the inputs above:

  • Terminal Revenue Growth - I'm using the risk-free rate (10-Yr bonds of Canada), because long term the company should not grow more than the rate of the economy. I'm using the risk-free rate as a proxy to it, so the terminal growth becomes it;
  • Terminal Cost of Capital - I'm assuming here the same value as the initial and estimated one;
  • Initial and Terminal Tax Rate - Used its historical average of ~30%;
  • Terminal ROIC - I've set it to a value a little higher than its terminal cost of capital given the very high values the company is returning currently. Later on we'll simulate other values using the Monte Carlo simulations.

All the other inputs were taken from the financial statement or from analyst projections.

The DCF gives us an estimated fair value of 254.04 dollars for Lululemon.

Something that we can also do now is to play around with Monte Carlo simulations. What this will allow us to do is to simulate multiple DCF valuations with pre-defined ranges for each of the inputs. Each simulation will randomize the inputs between these pre-defined values. For this I also used analysts estimates.

As you can see from the above Lululemon seems to be undervalued given that its current price of 165 dollars is well below P10. From these simulations we can extrapolate that there's more than 90% probability that the stock is undervalued at the current price.

As always take this single output, from this DCF valuation method, with a grain of salt. Let's move on to the other valuation methods to get a clearer picture.

Please be free, as before, to fill in your own values. Make the valuation your own and do yourself a DCF valuation using your own assumptions: DCF - The Fair Value Journal

EPS Growth (Weight: 20%)

For this valuation method, I've used the current EPS and the analysts estimates of EPS growth. I also assumed the company will bounce back a little to a 20 PE.

Then again, I used the Monte Carlo simulations to check how the estimated fair value changed as my assumptions were modified.

Using this method, Lululemon that is currently priced at 165 dollars seems to be undervalued being currently valued below P10. This seems to be in line with what we've seen during the DCF valuation.

As before, feel free to try this yourself: EPS Growth - The Fair Value Journal

EPS Scenario Returns

We can also extrapolate some EPS scenarios to check how the returns may be, if we buy the stock at the current prices.

Feel free to give it a try yourself: EPS Scenario Returns — The Fair Value Journal

Historical P/E (Weight: 10%)

The current P/E (Price / Earnings) ratio is below its 10 Year average. This means that the company is a undervalued by this metric. Assuming a mean reversion to its historical average of 40.31 we can assume a fair value of 278.96 dollars.

For every type of historical and relative valuation you can use the same free tool: Historical / Relative Valuation - The Fair Value Journal

Historical EV/EBITDA (Weight: 10%)

The current EV/EBITDA (Enterprise Value / Earnings Before Interests, Taxes, Depreciation and Amortization) ratio is below its 10 Year average. This means that the company is undervalued by this metric. Assuming a mean reversion to its historical average of 21.35 we can assume a fair value of 278.68 dollars.

Historical P/S (Weight: 10%)

The current P/S (Price / Sales) ratio is below its 10 Year average. This means that the company is undervalued by this metric. Assuming a mean reversion to its historical average of 5.28 we can assume a fair value of 278.44 dollars.

✍️Summary

Now that we did all the heavy work, let's take the above and come up with the company weighted average fair value.

I basically take each valuation method used and given my confidence on the company apply a 20% or 10% discount (when to buy) and addition (when to sell) or use the Monte Carlo P10, P20, P80 and P90 values:

Feel free to choose your own values and margin of safety, but for me I would probably start buying below the 222.48 dollars mark, given the current uncertainty about the moat durability of this company.

Please, as always, remember that the fair value estimate has a 100% probability of being wrong and it will never be a precise number, even if it has decimals next to it 😮

Overall it seems Lululemon is undervalued at its current market price.

Fair Value: 266.14 dollars

Have other thoughts on lululemon athletica?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

The user andre_santos has a position in NasdaqGS:LULU. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$265
FV
52.3% undervalued intrinsic discount
17.24%
Revenue growth p.a.
257
users have viewed this narrative
5users have liked this narrative
1users have commented on this narrative
8users have followed this narrative
US$234.5
FV
46.1% undervalued intrinsic discount
10.07%
Revenue growth p.a.
10
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative